Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07237516 · ClinicalTrials.gov registry record

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

A clinical trial of Ulcerative Colitis (UC) and Inflammatory Bowel Disease (IBD), sponsored by University of North Carolina, Chapel Hill.

Recruiting
Registry status
200
Enrollment target
5
Study locations

NCT07237516 is a study of Ulcerative Colitis (UC) and Inflammatory Bowel Disease (IBD) that is actively recruiting participants, run by University of North Carolina, Chapel Hill. The registered enrollment target is 200 participants, below the 753-participant average among 17 other Ulcerative Colitis (UC) trials with a reported enrollment target (73% lower). The trial reports 5 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07237516, a study of Ulcerative Colitis (UC) and Inflammatory Bowel Disease (IBD), is actively recruiting participants, sponsored by University of North Carolina, Chapel Hill.

RECRUITING
Registry status
200 participants
Enrollment target
5
Study locations

Study Summary

The goal of this observational study is to learn about how effective Zymfentra (IFX=dyyb) is when treating patients with Crohn's disease (CD) and ulcerative colitis (UC) Does Zymfentra lead to a reduction in symptoms at intervals throughout one year? Participants being prescribed Zymfentra (IFX-dyyb as part of their regular medical care for CD or UC will answer online survey questions about their bowel habits for 1 year.

Conditions Studied

Ulcerative Colitis (UC) Inflammatory Bowel Disease (IBD) Indeterminate Colitis Crohn's Disease (CD)

Study Locations (5)

Iowa

  • University of Iowa - Iowa City

Maryland

  • Mercy Medical Center - Baltimore

Massachusetts

  • Brigham and Women's Hospital - Boston

New York

  • New York University - New York

North Carolina

  • University of North Carolina - Chapel Hill

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2025-11-20
Est. Completion 2028-11-03

Sponsor

University of North Carolina, Chapel Hill

1,109 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07237516

The ClinicalTrials.gov registry entry for NCT07237516 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 753-participant average among 17 other Ulcerative Colitis (UC) trials with a reported enrollment target (73% lower). The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Ulcerative Colitis (UC) appearing as the primary indexed condition, and to 0 interventions.

NCT07237516 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Iowa, Maryland, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT07237516 about?

NCT07237516 is a clinical study titled "Zymfentra (Infliximab-dyyb) REal World Cohort STudy". The goal of this observational study is to learn about how effective Zymfentra (IFX=dyyb) is when treating patients with Crohn's disease (CD) and ulcerative colitis (UC) Does Zymfentra lead to a reduction in symptoms at intervals throughout one year? Participants being prescribed Zymfentra (IFX-dyyb...

What is the current status of trial NCT07237516?

This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2025-11-20. Estimated completion is 2028-11-03.

What conditions does trial NCT07237516 study?

This clinical trial studies the following conditions: Ulcerative Colitis (UC), Inflammatory Bowel Disease (IBD), Indeterminate Colitis, Crohn's Disease (CD).

Who is sponsoring clinical trial NCT07237516?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07237516 being conducted?

This trial has 5 study locations across Iowa, Maryland, Massachusetts, New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Ulcerative Colitis (UC)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Ulcerative Colitis (UC)

All registered trials for this condition

Inflammatory Bowel Disease (IBD)

All registered trials for this condition

Iowa

All trials with a study site in Iowa

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.